Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VEEV vs GSK✓SelectedUSD · GSKVEEV vs GSK performance historyLatest closeAs of+1.26%11/20
Stock and ETF performance explorer

VEEV vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+49.0%
GSK return
+53.4%
Excess return
-4.4%
Maximum drawdown
-50.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.3%-0.1%+1.4%+1.3%
7D-11.7%-5.3%-6.4%-11.1%
30D-16.9%-3.7%-13.3%-16.6%
3M+6.3%-7.3%+13.5%+7.2%
6M+61.4%-4.2%+65.6%+62.0%
YTD+19.3%+0.9%+18.4%+17.2%
1Y-1.6%+7.3%-8.9%-4.6%
3Y+49.0%+52.7%-3.8%+26.4%
All+49.0%+53.4%-4.4%+26.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling